Assignee
HUNILIFE BIOTECHNOLOGY INC
TW·0 granted patents·4 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
4 records- 0159US2025034278A1Use of alpha-enolase antagonist for treating angiogenesis-related diseasesHUNILIFE BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 0256US2025243294A1Methods to regulate glycolysis via targeting extracellular alpha-enolase for treating human diseasesHUNILIFE BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 0356US2025075005A1Use of alpha-enolase antagonist in treating of fibrotic diseasesHUNILIFE BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 0451US2024207433A1Drug conjugates containing alpha-enolase antibodies and uses thereofHUNILIFE BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HUNILIFE BIOTECHNOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →